Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.625 USD | +4.17% | +18.70% | +16.69% |
Apr. 24 | Avid Bioservices, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.69% | 465M | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-20.16% | 29.48B | |
+58.49% | 25.43B | |
-17.89% | 11.49B | |
-44.02% | 11.3B | |
-15.61% | 11.1B | |
+4.79% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices : to Manufacture ADC Therapeutics' Cancer Treatment Zynlonta